Growth Metrics

SOPHiA GENETICS (SOPH) Change in Receivables (2020 - 2025)

SOPHiA GENETICS's Change in Receivables history spans 6 years, with the latest figure at -$6.6 million for Q4 2025.

  • On a quarterly basis, Change in Receivables fell 419.1% to -$6.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$6.6 million, a 212.07% decrease, with the full-year FY2025 number at -$6.6 million, down 212.07% from a year prior.
  • Change in Receivables hit -$6.6 million in Q4 2025 for SOPHiA GENETICS, down from $1.3 million in the prior quarter.
  • Over the last five years, Change in Receivables for SOPH hit a ceiling of $3.0 million in Q4 2021 and a floor of -$6.6 million in Q4 2025.
  • Historically, Change in Receivables has averaged -$203650.0 across 5 years, with a median of $180000.0 in 2021.
  • Biggest five-year swings in Change in Receivables: skyrocketed 478.37% in 2021 and later crashed 158350.0% in 2023.
  • Tracing SOPH's Change in Receivables over 5 years: stood at $3.0 million in 2021, then crashed by 31.91% to $2.0 million in 2022, then plummeted by 278.77% to -$3.6 million in 2023, then surged by 157.43% to $2.1 million in 2024, then crashed by 419.1% to -$6.6 million in 2025.
  • Business Quant data shows Change in Receivables for SOPH at -$6.6 million in Q4 2025, $1.3 million in Q3 2025, and $1.7 million in Q2 2025.